244 related articles for article (PubMed ID: 8751307)
1. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.
Cullis JO; Win N; Dudley JM; Kaye T
Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307
[TBL] [Abstract][Full Text] [Related]
2. Hyperhaemolysis caused by anti-HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion.
Hinton R; Haji R; Kaczmarski R; Layton M; Danga A
Transfus Med; 2023 Aug; 33(4):349-351. PubMed ID: 37186414
[TBL] [Abstract][Full Text] [Related]
3. Prevention of potential delayed hemolytic transfusion reaction in two sickle cell patients using intravenous immunoglobulins and steroids before and after red blood cell exchange with antigen positive units and review literature.
Shold J; Dasgupta A; Ye Z
Transfus Apher Sci; 2024 Jun; 63(3):103920. PubMed ID: 38570214
[TBL] [Abstract][Full Text] [Related]
4. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
Win N; Sinha S; Lee E; Mills W
Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
6. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease.
Win N; Yeghen T; Needs M; Chen FE; Okpala I
Hematology; 2004; 9(5-6):433-6. PubMed ID: 15763986
[TBL] [Abstract][Full Text] [Related]
7. Hyperhemolytic transfusion reaction in sickle cell disease.
Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Balbuena-Merle R; Hendrickson JE
Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
[TBL] [Abstract][Full Text] [Related]
9. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
[TBL] [Abstract][Full Text] [Related]
10. Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.
Madu AJ; Ugwu AO; Efobi C
Med Princ Pract; 2021; 30(3):236-243. PubMed ID: 33176303
[TBL] [Abstract][Full Text] [Related]
11. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
Jacobs JW; Stephens LD; Allen ES; Binns TC; Booth GS; Hendrickson JE; Karafin MS; Tormey CA; Woo JS; Adkins BD
Br J Haematol; 2023 Jun; 201(6):1025-1032. PubMed ID: 37074146
[TBL] [Abstract][Full Text] [Related]
13. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
[TBL] [Abstract][Full Text] [Related]
14. When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease.
Chinchilla Langeber S; Osuna Marco MP; Benedit M; Cervera Bravo Á
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29588281
[TBL] [Abstract][Full Text] [Related]
15. Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.
Win N; Lee E; Needs M; Chia LW; Stasi R
Transfus Med; 2012 Apr; 22(2):137-41. PubMed ID: 22233101
[TBL] [Abstract][Full Text] [Related]
16. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.
Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z
Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670
[TBL] [Abstract][Full Text] [Related]
17. Histopathological evidence for macrophage activation driving post-transfusion hyperhaemolysis syndrome.
Win N; Lucas S; Hebballi S; McKernan A; Hamilton R; Robinson I; Chen F
Br J Haematol; 2019 Aug; 186(3):499-502. PubMed ID: 31020643
[TBL] [Abstract][Full Text] [Related]
18. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
Gardner K; Hoppe C; Mijovic A; Thein SL
Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood.
Win N; Madan B; Gale R; Matthey F
Hematology; 2005 Oct; 10(5):375-8. PubMed ID: 16273724
[TBL] [Abstract][Full Text] [Related]
20. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
Win N; New H; Lee E; de la Fuente J
Transfusion; 2008 Jun; 48(6):1231-8. PubMed ID: 18373500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
